231 related articles for article (PubMed ID: 31195598)
1. Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts.
Fujita M; Ito-Fujita Y; Iyoda T; Sasada M; Okada Y; Ishibashi K; Osawa T; Kodama H; Fukai F; Suzuki H
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195598
[TBL] [Abstract][Full Text] [Related]
2. Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin α5β1 by the Tenascin-C-Derived Peptide TNIIIA2.
Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Sasada M; Nagai R; Kudo C; Otsuka K; Kamiya S; Kodama H; Fukai F
Mol Cancer Ther; 2019 Sep; 18(9):1649-1658. PubMed ID: 31189613
[TBL] [Abstract][Full Text] [Related]
3. Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation.
Fujita M; Sasada M; Iyoda T; Nagai R; Kudo C; Yamamoto T; Osada S; Kodama H; Fukai F
Biochem Biophys Res Commun; 2021 Jan; 536():14-19. PubMed ID: 33360093
[TBL] [Abstract][Full Text] [Related]
4. Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression.
Fujita M; Suzuki H; Fukai F
World J Gastrointest Oncol; 2021 Sep; 13(9):980-994. PubMed ID: 34616507
[TBL] [Abstract][Full Text] [Related]
5. Induction of cellular senescence in fibroblasts through β1-integrin activation by tenascin-C-derived peptide and its protumor effect.
Fujita M; Sasada M; Eguchi M; Iyoda T; Okuyama S; Osawa T; Tsuzuranuki K; Sakamoto M; Hagihara Y; Matsumura M; Osada S; Kodama H; Higami Y; Fukai F
Am J Cancer Res; 2021; 11(9):4364-4379. PubMed ID: 34659892
[TBL] [Abstract][Full Text] [Related]
6. A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4.
Saito Y; Imazeki H; Miura S; Yoshimura T; Okutsu H; Harada Y; Ohwaki T; Nagao O; Kamiya S; Hayashi R; Kodama H; Handa H; Yoshida T; Fukai F
J Biol Chem; 2007 Nov; 282(48):34929-37. PubMed ID: 17901052
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-C Produced by Intestinal Myofibroblasts Promotes Colitis-associated Cancer Development Through Angiogenesis.
Kawamura T; Yamamoto M; Suzuki K; Suzuki Y; Kamishima M; Sakata M; Kurachi K; Setoh M; Konno H; Takeuchi H
Inflamm Bowel Dis; 2019 Mar; 25(4):732-741. PubMed ID: 30517646
[TBL] [Abstract][Full Text] [Related]
8. Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells.
Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Nagai R; Kudo C; Sasada M; Kodama H; Fukai F
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261783
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins.
Saito Y; Shiota Y; Nishisaka M; Owaki T; Shimamura M; Fukai F
Biol Pharm Bull; 2008 May; 31(5):1003-7. PubMed ID: 18451535
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.
Fujita M; Sasada M; Iyoda T; Fukai F
Molecules; 2020 Jul; 25(14):. PubMed ID: 32708610
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1.
Tanaka R; Seki Y; Saito Y; Kamiya S; Fujita M; Okutsu H; Iyoda T; Takai T; Owaki T; Yajima H; Taira J; Hayashi R; Kodama H; Matsunaga T; Fukai F
J Biol Chem; 2014 Jun; 289(25):17699-708. PubMed ID: 24808173
[TBL] [Abstract][Full Text] [Related]
12. Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma.
Iyoda T; Fujita M; Fukai F
Front Immunol; 2020; 11():610096. PubMed ID: 33362799
[TBL] [Abstract][Full Text] [Related]
13. Bioactive TNIIIA2 Sequence in Tenascin-C Is Responsible for Macrophage Foam Cell Transformation; Potential of FNIII14 Peptide Derived from Fibronectin in Suppression of Atherosclerotic Plaque Formation.
Iyoda T; Ohishi A; Wang Y; Yokoyama MS; Kazama M; Okita N; Inouye S; Nakagawa Y; Shimano H; Fukai F
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339104
[TBL] [Abstract][Full Text] [Related]
14. The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration.
Suzuki H; Sasada M; Kamiya S; Ito Y; Watanabe H; Okada Y; Ishibashi K; Iyoda T; Yanaka A; Fukai F
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106752
[TBL] [Abstract][Full Text] [Related]
15. AOM/DSS Model of Colitis-Associated Cancer.
Parang B; Barrett CW; Williams CS
Methods Mol Biol; 2016; 1422():297-307. PubMed ID: 27246042
[TBL] [Abstract][Full Text] [Related]
16. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
[No Abstract] [Full Text] [Related]
17. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.
Tian Y; Xu Q; Sun L; Ye Y; Ji G
J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938
[TBL] [Abstract][Full Text] [Related]
18. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.
Means AL; Freeman TJ; Zhu J; Woodbury LG; Marincola-Smith P; Wu C; Meyer AR; Weaver CJ; Padmanabhan C; An H; Zi J; Wessinger BC; Chaturvedi R; Brown TD; Deane NG; Coffey RJ; Wilson KT; Smith JJ; Sawyers CL; Goldenring JR; Novitskiy SV; Washington MK; Shi C; Beauchamp RD
Cell Mol Gastroenterol Hepatol; 2018; 6(3):257-276. PubMed ID: 30109253
[TBL] [Abstract][Full Text] [Related]
19. [Inflammation promotes the development of colitis-associated colorectal cancer].
He Z; Ke J; He X; Lian L; Sun L; Chen Z; Wu X; Lan P
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jul; 17(7):706-10. PubMed ID: 25070454
[TBL] [Abstract][Full Text] [Related]
20. BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
Liu X; Wei W; Li X; Shen P; Ju D; Wang Z; Zhang R; Yang F; Chen C; Cao K; Zhu G; Chen H; Chen L; Sui J; Zhang E; Wu K; Wang F; Zhao L; Xi R
Gastroenterology; 2017 Dec; 153(6):1607-1620. PubMed ID: 28780076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
